Product

Company

NCT00566111·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Yale University

With

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

Hypersensitivity to penicillin or cephalosporin, resulting in anaphylaxis
Significant current substance dependence/abuse within 3 months preceding the trial
Significant history of intravenous drug abuse
Active suicidal ideation
Pregnant/lactating mothers
Significant medical history
Patients on anticoagulation treatment
Patients who test positive for HIV or Hep B or C

The record

StatusTerminated

PhaseNo phase

Taking part5

StartedSep 2007

UpdatedMar 31, 2020

Conditions

Where1

Clareo Health | Ceftriaxone in the Management of Bipolar Depression